Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2

Circulation Research

Volumn 86, Issue 1, 2000, Pages 51-58

  Kunst, Gudrun ^a   Kress, Kai R ^a   Gruen, Mathias ^b   Uttenweiler, Dietmar ^a   Gautel, Mathias ^b   Fink, Rainer H A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Contraction regulation; Familial hypertrophic cardiomyopathy; Myosin binding protein C; Protein phosphorylation

Indexed keywords

CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOSIN; MYOSIN BINDING PROTEIN C;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STIFFNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 0033972217     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.1.51     Document Type: Article

References (58)

1. Carrier L, Bonne G, Schwartz K. Cardiac myosin-binding protein C and hypertrophic cardiomyopathy. Trends Cardiovasc Med. 1998;8:151-157.
2. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg H-P, Fiszman M, Komajda M, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438-440.
3. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin-binding protein-C on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
4. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagège AA, Trent RJ, Komajda M, Fiszman M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 1997;80:427-434.
5. Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Grünig E, Brown BD, Vollrath B, Mall G, Dietz R, Katus HA. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of transcript and protein. J Clin Invest. 1997;100:475-482.
6. Yu B, French JA, Carrier L, Jeremy RW, McTaggart DR, Nicholson MR, Hambly B, Semsarian C, Richmond DR, Schwartz K, Trent RJ. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein-C gene. J Med Genet. 1997;35:205-210.
7. Moolman Smook JC, Mayosi B, Brink P, Corfield VA. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. J Med Genet. 1998;35:253-254.
8. Niimura H, Bachinski L, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein-C and late onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257.
9. Winegrad S. Cardiac myosin binding protein C. Circ Res. 1999;84: 1117-1126.
10. Fougerousse F, Delezoide AL, Fiszman MY, Schwartz K, Beckmann JS, Carrier L. Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development. Circ Res. 1998;82:130-133.
11. Gautel M, Fürst DO, Cocco A, Schiaffino S. Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. Circ Res. 1998;82:124-129.
12. Jeacocke S, England P. Phosphorylation of a myofibrillar protein of Mr 15 0000 in perfused rat heart, and the tentative identification of this as C-protein. FEBS Lett. 1980;122:129-132.
13. Hartzell HC, Titus L. Effects of cholinergic and adrenergic agonists on phosphorylation of 165,000-dalton myofibrillar protein in intact cardiac muscle. J Biol Chem. 1982;257:2111-2120.
14. 2+-calmodulin-dependent protein kinases. J Biol Chem. 1984;259:15587-15596.
15. Garvey JL, Kranias EG, Solaro RJ. Phosphorylation of C-protein, troponin-I and phospholamban in isolated rabbit hearts. Biochem J. 1988;249:709-714.
16. Schlender KK, Bean LJ. Phosphorylation of chicken cardiac C-protein by calcium/calmodulin-dependent protein kinase II. J Biol Chem. 1991;266:2811-2817.
17. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J. 1995;14:1952-1960.
18. Gruen M, Gautel M. Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin binding protein-C. J Mol Biol. 1999; 286:933-949.
19. Sébillion P, Bonne G, Flavigny J, Venin S, Wisnewsky C, Vikström K, Leinwand L, Carrier L, Schwartz K. Impact of C-terminal truncation of human cardiac myosin binding protein C on myosin filament organization. Circulation. 1998;98(suppl I):I-235. Abstract.
20. Gruen M, Prinz H, Gautel M. cAPK-Phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett. 1999;453:254-9.
21. Knight PJ. Dynamic behaviour of the head-tail junction of myosin. J Mol Biol. 1996;255:269-274.
22. Offer G, Knight PJ. The structure of the head-tail junction of the myosin molecule. J Mol Biol. 1996;256:407-416.
23. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest. 1998;102:1292-1300.
24. Ford LE, Huxley AF, Simmons RM. The relation between stiffness and filament overlap in stimulated frog muscle fibres. J Physiol (Lond). 1981;311:219-249.
25. Offer G, Moos C, Starr R. A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization. J Mol Biol. 1973;74:653-676.
26. Craig R, Offer G. The location of C-protein in rabbit skeletal muscle. Proc R Soc Lond B Biol Sci. 1976;192:451-461.
27. Freiburg A, Gautel M. A molecular map of the interactions of titin and myosin-binding protein C: implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem. 1996;235: 317-323.
28. Kraft T, Messerli M, Rothen-Rutishauser B, Perriard JC, Wallimann T, Brenner B. Equilibration and exchange of fluorescently labeled molecules in skinned skeletal muscle fibers visualized by confocal microscopy. Biophys J. 1995;69:1246-1258.
29. 2+. J Physiol (Lond). 1990;420:337-353.
30. Veigel CV, Maydell RD, Wiegand-Steubing R, Goody R, Fink HA. The influence of ionic strength upon relaxation from rigor induced by flash photolysis of caged-ATP in skinned murine skeletal muscle fibres. Pflugers Arch. 1995;430:994-1003.
31. Veigel C, von Maydell R, Kress K, Molloy J, Fink R. The effect of ionic strength on rigor. Eur J Physiol (Pfluegers Arch). 1998;435: 753-761.
32. Stephenson DG, Williams DA. Calcium-activated force responses in fast- and slow-twitch skinned muscle fibres of the rat at different temperatures. J Physiol (Lond). 1981;317:281-302.
33. Linke WA, Ivemeyer M, Labeit S, Hinssen H, Rüegg JC, Gautel M. Actin-titin interaction in cardiac myofibrils: probing a physiological role. Biophys J. 1997;73:905-919.
34. Tskhovrebova L, Trinick J, Sleep JA, Simmons RM. Elasticity and unfolding of single molecules of the giant muscle protein titin. Nature. 1997;387:308-312.
35. Valle G, Faulkner G, De Antoni A, Pacchioni B, Pallavacini A, Pandolfo D, Tiso N, Toppo S, Trevisan, Lanfranchi G. Telethonin, a novel sarcomeric protein of heart and skeletal muscle. FEBS Lett. 1997;415:163-168.
36. Goldman YE, Simmons RM. Active and rigor muscle stiffness. J Physiol (Lond). 1977;269:55P-57P.
37. Hove-Madsen L, Mery PF, Jurevicius J, Skeberdis AV, Fischmeister R. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol. 1996;91(suppl 2):1-8.
38. Kogler H, Ruegg JC. Cardiac contractility: modulation of myofibrillar calcium sensitivity by β-adrenergic stimulation. Isr J Med Sci. 1997; 33:1-7.
39. Lehrer SS, Geeves MA. The muscle thin filament as a classical cooperative/allosteric regulatory system. J Mol Biol. 1998;277: 1081-1089.
40. Yamamoto K. The binding of skeletal muscle C-protein to regulated actin. FEBS Lett. 1986;208:123-127.
41. Moos C, Mason CM, Besterman JM, Feng IM, Dubin JH. The binding of skeletal muscle C-protein to F-actin and its relation to the interaction of actin with myosin subfragment-1. J Mol Biol. 1978; 124: 571-586.
42. Weisberg A, Winegrad S. Relation between crossbridge structure and actomyosin ATPase activity in rat heart. Circ Res. 1998;83:60-72.
43. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA. 1996;93:8999-9003.
44. Hirose K, Franzini-Armstrong C, Goldman YE, Murray JM. Structural changes in muscle crossbridges accompanying force generation. J Cell Biol. 1994;127:763-778.
45. 2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol. 1991;97: 1141-1163.
46. Hofmann PA, Lange JH. Effects of phosphorylation of troponin I and C protein on isometric tension and velocity of unloaded shortening in skinned single cardiac myocytes from rats. Circ Res. 1994;74:718-726.
47. Holmes KC, Goody RS. The nature of the actin cross-bridge interaction. Adv Exp Med Biol. 1984;170:373-384.
48. Schaub MC, Watterson JG. Symmetry and asymmetry in the contractile protein myosin. Biochimie. 1981;63:291-299.
49. Conibear PB, Geeves MA. Cooperativity between the two heads of rabbit skeletal muscle heavy meromyosin in binding to actin. Biophys J. 1998;75:926-937.
50. Tyska MJ, Dupuis DE, Guilford WH, Patlak JB, Waller GS, Trybus ICM, Warshaw DM, Lowey S. Two heads of myosin are better than one for generating force and motion. Proc Natl Acad Sci U S A. 1999;96:4402-4407.
51. Allen DG, Kentish JC. The cellular basis of the length-tension relation in cardiac muscle. J Mol Cell Cardiol. 1985;17:821-840.
52. Winegrad S. Regulation of cardiac contractile proteins. Correlations between physiology and biochemistry. Circ Res. 1984;55:565-574.
53. 2+ sensitivity of tension in mouse cardiac myocytes expressing skeletal troponin C. J Physiol (Lond). 1995;483:131-139.
54. Sugi H, Kobayashi T, Gross T, Noguchi K, Karr T, Harrington WF. Contraction characteristics and ATPase activity of skeletal muscle fibers in the presence of antibody to myosin subfragment 2. Proc Natl Acad Sci USA. 1992;89:6134-6137.
55. Kobayashi T, Kosuge S, Sugi H. Bidirectional functional communication between myosin subfragments 1 and 2 in skeletal muscle fibers. Adv Exp Med Biol. 1998;453:435-440.
56. 2+ sensitivity of tension. J Physiol (Lond). 1991;440:273-289.
57. 2+-tension relationship in aequorin-injected ferret papillary muscles. Am J Physiol. 1997;273:H1068-H1074.
58. Schoenberg M. Crossbridge head detachment rate constants determined from a model that explains the behavior of both weakly- and strongly-binding crossbridges. Adv Exp Med Biol. 1998;453: 425-433.